1446091-32-2Relevant academic research and scientific papers
FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS
-
Paragraph 0181-0182; 0187-0188, (2021/02/16)
Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.
Condensed tricyclic compounds as RAF kinase inhibitors
-
Paragraph 0313; 0314; 0315; 0322; 0323; 0324, (2016/10/07)
The invention provides certain condensed tricyclic compounds as well as salt, compositions and application methods thereof.
CONDENSED TRICYCLIC COMPOUNDS AS Raf KINASE INHIBITORS
-
Paragraph 0121; 0124, (2017/01/05)
PROBLEM TO BE SOLVED: To provide specific tricyclic compounds that can be useful for inhibiting Raf kinase and for treating disorders mediated by Raf kinase. SOLUTION: A compound is represented by the general formula 1 in the figure. (Q is C or N; W is C or N; X is CH2 or O; Y is NR12, O or S; Z is O, S, NR13, CO, SO, SO2 or CR13R14; R1 to R6 are each independently hydrogen, halogen, haloalkyl, alkyl or the like.) SELECTED DRAWING: None COPYRIGHT: (C)2017,JPO&INPIT
FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS
-
Paragraph 0216; 0221-0222, (2015/02/25)
Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.
FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS
-
Page/Page column 35, (2013/07/19)
Provided are certain fused tricyclic compounds and salts thereof, compositions thereof, and methods of use therefor.
